Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 31 AL 45

Drugs repurposing in the experimental models of Alzheimer's disease

Joodi SA, Ibrahim WW, Khattab MM.

Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Dawood RA, Albuhadily AK, Al-Gareeb AI, Abomughaid MM, Klionsky DJ.

Neuropsychopharmacol Rep. 2025 Mar;45(1):e12525. doi: 10.1002/npr2.12525.

Neuroactive Phytoconstituents of Glycyrrhiza glabra for the Treatment of Alzheimer's Disease

Verma M, Mohd Siddique MU, Singh NK.

Curr Top Med Chem. 2025;25(10):1251-1265. doi: 10.2174/0115680266357793241223100307.

C/EBPβ in Alzheimer's disease: An integrative regulator of pathological mechanisms

Luo X, Liang J, Lei X, Sun F, Gong M, Liu B, Zhou Z.

Brain Res Bull. 2025 Feb;221:111198. doi: 10.1016/j.brainresbull.2025.111198. Epub 2025 Jan 7.

Gut microbiota in Alzheimer's disease: Understanding molecular pathways and potential therapeutic perspectives

Lista S, Munafò A, Caraci F, Imbimbo C, Emanuele E, Minoretti P, Pinto-Fraga J, Merino-País M, Crespo-Escobar P, López-Ortiz S, Monteleone G, Imbimbo BP, Santos-Lozano A.

Ageing Res Rev. 2025 Feb;104:102659. doi: 10.1016/j.arr.2025.102659. Epub 2025 Jan 10.

Evolution of Human Susceptibility to Alzheimer's Disease: A Review of Hypotheses and Comparative Evidence

August I, Gagneux P, Semendeferi K, Marchetto MC.

Evol Anthropol. 2025 Mar;34(1):e22054. doi: 10.1002/evan.22054.

Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease

Li Y, Han Y, Shu Q, Kan YK, Wang Z.

Biomed Pharmacother. 2025 Feb;183:117814. doi: 10.1016/j.biopha.2025.117814. Epub 2025 Jan 13.

Senescence accelerated mouse-prone 8: a model of neuroinflammation and aging with features of sporadic Alzheimer's disease

Ong J, Sasaki K, Ferdousi F, Suresh M, Isoda H, Szele FG.

Stem Cells. 2025 Feb 12;43(2):sxae091. doi: 10.1093/stmcls/sxae091.

Mathematical models on Alzheimer's disease and its treatment: A review

Maji M, Khajanchi S.

Phys Life Rev. 2025 Mar;52:207-244. doi: 10.1016/j.plrev.2025.01.004. Epub 2025 Jan 10.

Multi-Targeting Phytochemicals for Alzheimer's Disease

Bhattacharya RS, Singh R, Panghal A, Thakur A, Singh L, Verma RK, Singh C, Goyal M, Kumar J.

Phytother Res. 2025 Mar;39(3):1453-1483. doi: 10.1002/ptr.8435. Epub 2025 Jan 15.

Epigenetics in Neurodegenerative Diseases

van Zundert B, Montecino M.

Subcell Biochem. 2025;108:73-109. doi: 10.1007/978-3-031-75980-2_3.

Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype

Ateya NH, Al-Taie SF, Jasim SA, Uthirapathy S, Chaudhary K, Rani P, Kundlas M, Naidu KS, Amer NA, Ahmed JK.

Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.

Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease

Zulhafiz NA, Teoh TC, Chin AV, Chang SW.

Comput Methods Programs Biomed. 2025 Apr;261:108604. doi: 10.1016/j.cmpb.2025.108604. Epub 2025 Jan 13.

Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review

Moradi F, Mokhtari T.

J Biochem Mol Toxicol. 2025 Feb;39(2):e70071. doi: 10.1002/jbt.70071.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias